Literature DB >> 27714469

Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients.

Daniele Bosone1, Roberto Fogari2, Matteo Cotta Ramusino1,3, Natascia Ghiotto1, Elena Guaschino1, Annalisa Zoppi4, Angela D'Angelo4, Alfredo Costa1,3.   

Abstract

The aim of the study was to evaluate the usefulness of Holter monitoring for the detection of silent myocardial ischemia (SMI) in elderly type 2 diabetic patients with hypertension and the possible relationship between SMI and cardiovascular autonomic neuropathy (CAN). Two hundred and forty-three asymptomatic outpatients, aged 65-75 years, with type 2 diabetes and essential hypertension underwent 24-h ECG monitoring and 5 tests for the evaluation of both parasympathetic (heart rate variability, response to breath deeping, and Valsalva manoeuvre) and sympathetic (cold pressor test and orthostatic hypotension test) autonomic function. A total of 518 asymptomatic episodes of ST depression during Holter monitoring indicative of SMI were detected in 51 of the 243 studied patients (20.9 %). None of the patients with ST depression episodes exhibited a normal response to at least one of the evaluated autonomic function tests, whereas 22 of the 192 patients without ST changes (11.4 %) exhibited a normal response to all tests. Abnormality in both parasympathetic and sympathetic function test responses was found in 94.1 % of patients with ST depression episodes vs 26.1 % of those without ST changes (P < 0.001). Statistical evaluation of the relationship between the abnormal response to single autonomic function test and episodes of ST depression was highly significant for all the 5 tests (P < 0.001). These results indicate that: (a) Holter monitoring enables to detect ST segment changes indicative of SMI in 20.9 % of elderly diabetic patients with hypertension; (b) the presence of autonomic cardiac dysfunction in these patients suggests a role of diabetic neuropathy in the pathogenesis of SMI; and (c) findings of severe autonomic dysfunction in more than 25 % of patients without ST depression episodes suggest that these patients might be at risk of myocardial ischemia and should possibly be addressed to closer specialistic evaluation, since Holter monitoring might have not detected SMI in these patients due to its low sensitivity and relatively short duration of recordings.

Entities:  

Keywords:  24-h Holter monitoring; Cardiac dysautonomia; Diabetes; Silent myocardial ischemia

Mesh:

Year:  2016        PMID: 27714469     DOI: 10.1007/s00380-016-0898-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  44 in total

Review 1.  Silent coronary artery disease in diabetes--a feature of autonomic neuropathy or accelerated atherosclerosis?

Authors:  K E Airaksinen
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

Review 2.  Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations.

Authors:  J Puel; P Valensi; G Vanzetto; V Lassmann-Vague; J-L Monin; Ph Moulin; Ch Ziccarelli; H Mayaudon; M Ovize; S Bernard; E Van Belle; S Halimi
Journal:  Diabetes Metab       Date:  2004-06       Impact factor: 6.041

3.  Asymptomatic coronary artery disease in diabetes: associated with autonomic neuropathy?

Authors:  M J Koistinen; K E Airaksinen; H V Huikuri; H Pirttiaho; M K Linnaluoto; M J Ikäheimo; J T Takkunen
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

4.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

5.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

6.  The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes.

Authors:  Jeroen J Bax; Robert O Bonow; Diethelm Tschöpe; Silvio E Inzucchi; Eugene Barrett
Journal:  J Am Coll Cardiol       Date:  2006-07-24       Impact factor: 24.094

7.  [Silent myocardial ischemia during Holter monitoring in patients with diabetes mellitus].

Authors:  E Marín Huerta; I Rayo; J I Lara; L Cuéllar; H de la Calle; J Romero; A del Río; A Muela; V Aza
Journal:  Rev Esp Cardiol       Date:  1989-10       Impact factor: 4.753

8.  Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies.

Authors:  Lihua Zhang; Hong Li; Simin Zhang; Lindsay M Jaacks; Yufeng Li; Linong Ji
Journal:  J Diabetes Complications       Date:  2013-12-10       Impact factor: 2.852

9.  Holter monitoring for the screening of cardiac disease in diabetes mellitus: The non-invasive Holter monitoring observation of new cardiac events in diabetics study.

Authors:  Yoko M Nakao; Kenji Ueshima; Ryuji Nohara; Yoshimi Mizunuma; Ikuo Segawa; Sachiko Tanaka-Mizuno; Shinji Yasuno; Kazuwa Nakao; Katsuhiko Hiramori; Yasuki Kihara
Journal:  Diab Vasc Dis Res       Date:  2015-08-05       Impact factor: 3.291

10.  Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.

Authors:  A Langer; M R Freeman; R G Josse; P W Armstrong
Journal:  J Am Coll Cardiol       Date:  1995-03-01       Impact factor: 24.094

View more
  4 in total

Review 1.  Autonomic dysfunction and heart rate variability with Holter monitoring: a diagnostic look at autonomic regulation.

Authors:  Beatrice De Maria; Laura Adelaide Dalla Vecchia; Alberto Porta; Maria Teresa La Rovere
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-07-08

2.  Nomogram Model Based on Clinical Risk Factors and Heart Rate Variability for Predicting All-Cause Mortality in Stage 5 CKD Patients.

Authors:  Xueyan Gao; Jing Wang; Hui Huang; Xiaoxue Ye; Ying Cui; Wenkai Ren; Fangyan Xu; Hanyang Qian; Zhanhui Gao; Ming Zeng; Guang Yang; Yaoyu Huang; Shaowen Tang; Changying Xing; Huiting Wan; Lina Zhang; Huimin Chen; Yao Jiang; Jing Zhang; Yujie Xiao; Anning Bian; Fan Li; Yongyue Wei; Ningning Wang
Journal:  Front Genet       Date:  2022-05-16       Impact factor: 4.772

3.  Distribution of the Indicator of the Appropriate Admission of Patients with Circulatory System Diseases to County Hospitals in Rural China: A Cross-Sectional Study.

Authors:  Qing Ye; Yan Zhang; Hong-Xia Gao; Ying-Chun Chen; Hao-Miao Li; Hui Zhang; Xiao-Mei Hu; Shi-Han Lei; Di Jiang
Journal:  Int J Environ Res Public Health       Date:  2019-05-09       Impact factor: 3.390

4.  Assessment of Hypertension Using Clinical Electrocardiogram Features: A First-Ever Review.

Authors:  Kathleen Bird; Gabriel Chan; Huiqi Lu; Heloise Greeff; John Allen; Derek Abbott; Carlo Menon; Nigel H Lovell; Newton Howard; Wee-Shian Chan; Richard Ribon Fletcher; Aymen Alian; Rabab Ward; Mohamed Elgendi
Journal:  Front Med (Lausanne)       Date:  2020-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.